$REX
REX American Resources Corp Stock $rex

$rex Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000093041323001143 Filed on March 30, 2023

Income Statement

Concept	2023 Q1	2023	2022 Q1
Revenue	$200.2M	$855.0M	$212.0M
YoY Change	-5.59%	10.35%	68.27%
Cost Of Revenue	$185.3M	$800.3M	$172.8M
YoY Change	7.19%	18.25%	45.0%
Gross Profit	$14.90M	$54.73M	$39.18M
YoY Change	-61.97%	-44.19%	476.13%
Gross Profit Margin	7.44%	6.4%	18.48%
Selling, General & Admin	$6.719M	$28.96M	$6.032M
YoY Change	11.39%	1.69%	37.09%
% of Gross Profit	45.1%	52.91%	15.4%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.473M	$17.98M	$4.526M
YoY Change	-1.17%	-0.31%	-12.96%
% of Gross Profit	30.02%	32.84%	11.55%
Operating Expenses	$6.719M	$28.96M	$6.032M
YoY Change	11.39%	1.69%	40.28%
Operating Profit	$8.180M	$25.78M	$33.15M
YoY Change	-75.32%	-62.96%	1225.8%
Interest Expense	$2.535M	$8.745M	$3.861M
YoY Change	-34.34%	32.02%	1187.0%
% of Operating Profit	30.99%	33.93%	11.65%
Other Income/Expense, Net	$2.621M	$12.96M	$13.00K
YoY Change	20061.54%	9868.46%	-96.75%
Pretax Income	$13.34M	$47.48M	$36.62M
YoY Change	-63.58%	-37.39%	1044.34%
Income Tax	$2.168M	$9.542M	$10.70M
% Of Pretax Income	16.26%	20.1%	29.23%
Net Earnings	$8.161M	$27.70M	$21.43M
YoY Change	-61.91%	-47.11%	512.17%
Net Earnings / Revenue	4.08%	3.24%	10.11%
Basic Earnings Per Share		$1.57
Diluted Earnings Per Share	$0.47	$1.57	$400.4K
COMMON SHARES
Basic Shares Outstanding	17.39M shares	17.64M shares
Diluted Shares Outstanding		17.64M shares

Balance Sheet

Concept	2023 Q1	2023	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$280.9M	$280.9M	$255.7M
YoY Change	9.86%	9.86%	41.52%
Cash & Equivalents	$69.61M	$69.61M	$229.8M
Short-Term Investments	$211.3M	$211.3M	$25.88M
Other Short-Term Assets	$14.83M	$14.83M	$14.72M
YoY Change	0.76%	0.76%	2.23%
Inventory	$48.74M	$48.74M	$42.23M
Prepaid Expenses
Receivables	$25.16M	$25.16M	$25.82M
Other Receivables	$2.962M	$2.962M	$6.677M
Total Short-Term Assets	$372.6M	$372.6M	$345.2M
YoY Change	7.96%	7.96%	33.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$135.5M	$150.7M	$148.8M
YoY Change	-8.92%	1.3%	-10.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$33.05M	$33.05M	$30.57M
YoY Change	8.11%	8.11%	3.61%
Other Assets	$23.18M	$23.18M	$25.85M
YoY Change	-10.34%	-10.34%	2.19%
Total Long-Term Assets	$206.9M	$206.9M	$205.2M
YoY Change	0.85%	0.85%	-6.94%
TOTAL ASSETS
Total Short-Term Assets	$372.6M	$372.6M	$345.2M
Total Long-Term Assets	$206.9M	$206.9M	$205.2M
Total Assets	$579.6M	$579.6M	$550.4M
YoY Change	5.31%	5.31%	14.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$34.09M	$34.09M	$32.27M
YoY Change	5.66%	5.66%	90.92%
Accrued Expenses	$15.33M	$20.51M	$17.19M
YoY Change	-10.83%	19.31%	43.24%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$54.60M	$54.60M	$50.48M
YoY Change	8.15%	8.15%	64.44%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.034M	$12.89M	$9.184M
YoY Change	-66.96%	40.34%	19.27%
Total Long-Term Liabilities	$13.99M	$12.89M	$9.184M
YoY Change	52.29%	40.34%	19.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$54.60M	$54.60M	$50.48M
Total Long-Term Liabilities	$13.99M	$12.89M	$9.184M
Total Liabilities	$68.59M	$131.6M	$119.6M
YoY Change	-42.64%	10.06%	26.39%
SHAREHOLDERS EQUITY
Retained Earnings	$640.8M		$611.6M
YoY Change	4.78%
Common Stock	$877.0K		$299.0K
YoY Change	193.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$193.7M		$181.1M
YoY Change	6.96%
Treasury Stock Shares	12.46M shares		12.09M shares
Shareholders Equity	$448.0M	$448.0M	$430.8M
YoY Change
Total Liabilities & Shareholders Equity	$579.6M	$579.6M	$550.4M
YoY Change	5.31%	5.31%	14.83%

Cashflow Statement

Concept	2023 Q1	2023	2022 Q1
OPERATING ACTIVITIES
Net Income	$8.161M	$27.70M	$21.43M
YoY Change	-61.91%	-47.11%	512.17%
Depreciation, Depletion And Amortization	$4.473M	$17.98M	$4.526M
YoY Change	-1.17%	-0.31%	-12.96%
Cash From Operating Activities	$801.0K	$54.80M	$41.28M
YoY Change	-98.06%	-40.25%	-420.0%
INVESTING ACTIVITIES
Capital Expenditures	$8.396M	$15.58M	-$881.0K
YoY Change	-1053.01%	-403.9%	-76.82%
Acquisitions
YoY Change
Other Investing Activities	-$56.09M	-$182.9M	-$4.230M
YoY Change	1225.89%	-1855.56%	-39.57%
Cash From Investing Activities	-$64.48M	-$198.5M	-$5.111M
YoY Change	1161.61%	-3849.66%	-52.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$13.01M	$0.00
YoY Change		-296.35%	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.267M	-$17.01M	-3.233M
YoY Change	-29.88%	53.3%	-21.15%
NET CHANGE
Cash From Operating Activities	801.0K	$54.80M	41.28M
Cash From Investing Activities	-64.48M	-$198.5M	-5.111M
Cash From Financing Activities	-2.267M	-$17.01M	-3.233M
Net Change In Cash	-65.95M	-$160.7M	32.94M
YoY Change	-300.23%	-287.08%	-218.47%
FREE CASH FLOW
Cash From Operating Activities	$801.0K	$54.80M	$41.28M
Capital Expenditures	$8.396M	$15.58M	-$881.0K
Free Cash Flow	-$7.595M	$39.22M	$42.16M
YoY Change	-118.01%	-59.5%	-563.31%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	rex	Investment In Cooperative Fair Value Disclosure InvestmentInCooperativeFairValueDisclosure	354000	usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-01-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2023	dei	Entity File Number EntityFileNumber	001-09097
CY2023	dei	Entity Registrant Name EntityRegistrantName	REX AMERICAN RESOURCES CORPORATION
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	23179000	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	25853000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	33045000	usd
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	30566000	usd
CY2023Q1	us-gaap	Assets Assets	579579000	usd
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	31-1095548
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	7720 Paragon Road
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Dayton
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	45459
CY2023	dei	City Area Code CityAreaCode	937
CY2023	dei	Local Phone Number LocalPhoneNumber	276-3931
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $.01 par value
CY2023	dei	Trading Symbol TradingSymbol	REX
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Public Float EntityPublicFloat	493699933	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17390019	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69612000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	229846000	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	211331000	usd
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	25877000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1735000	usd
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	2222000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25162000	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25821000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	48744000	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	42225000	usd
CY2023Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2962000	usd
CY2022Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	6677000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	13098000	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12499000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	372644000	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	345167000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	135497000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	137554000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15214000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11221000	usd
CY2022Q1	us-gaap	Assets Assets	550361000	usd
CY2023Q1	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1500	usd
CY2022Q1	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	500	usd
CY2023Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	34091000	usd
CY2022Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	32266000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5180000	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4600000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15328000	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13617000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	54599000	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	50483000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1097000	usd
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3132000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9855000	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6390000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3034000	usd
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2794000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	13986000	usd
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12316000	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29853000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29853000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	299000	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	299000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	578000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	640826000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	611607000	usd
CY2023Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	12463000	shares
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	12092000	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	193721000	usd
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	181114000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	447982000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	430792000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	63012000	usd
CY2022Q1	us-gaap	Minority Interest MinorityInterest	56770000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	510994000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	487562000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	579579000	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	550361000	usd
CY2023	us-gaap	Revenues Revenues	855000000	usd
CY2022	us-gaap	Revenues Revenues	774802000	usd
CY2021	us-gaap	Revenues Revenues	372664000	usd
CY2023	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	135400000	usd
CY2022	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	90200000	usd
CY2021	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	54800000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	800269000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	677242000	usd
CY2021	rex	Income Loss Per Share From Continuing Operations Basic And Diluted IncomeLossPerShareFromContinuingOperationsBasicAndDiluted	0.1	usd
CY2022	rex	Income Loss Per Share From Discontinued Operations Basic And Diluted IncomeLossPerShareFromDiscontinuedOperationsBasicAndDiluted	0.27	usd
CY2021	rex	Income Loss Per Share From Discontinued Operations Basic And Diluted IncomeLossPerShareFromDiscontinuedOperationsBasicAndDiluted	0.06	usd
CY2023	rex	Net Income Per Share Basic And Diluted NetIncomePerShareBasicAndDiluted	1.57	usd
CY2022	rex	Net Income Per Share Basic And Diluted NetIncomePerShareBasicAndDiluted	2.92	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	353131000	usd
CY2023	us-gaap	Gross Profit GrossProfit	54731000	usd
CY2022	us-gaap	Gross Profit GrossProfit	97560000	usd
CY2021	us-gaap	Gross Profit GrossProfit	19533000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	28956000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	28476000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17639000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	8745000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6624000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	500000	usd
CY2023	us-gaap	Interest And Other Income InterestAndOtherIncome	12959000	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	130000	usd
CY2021	us-gaap	Interest And Other Income InterestAndOtherIncome	1818000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	47479000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	75838000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4212000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9542000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19031000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-546000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	37937000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	56807000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	4758000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	10240000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	9235000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	2878000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	27697000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	47572000	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1880000	usd
CY2022	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	300000	usd
CY2021	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	-200000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	4395000	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	860000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-397000	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-261000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	4792000	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	1121000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	27697000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	52364000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3001000	usd
CY2023	rex	Weighted Average Shares Outstanding Basic And Diluted WeightedAverageSharesOutstandingBasicAndDiluted	17638000	usd
CY2022	rex	Weighted Average Shares Outstanding Basic And Diluted WeightedAverageSharesOutstandingBasicAndDiluted	17946000	usd
CY2021	rex	Weighted Average Shares Outstanding Basic And Diluted WeightedAverageSharesOutstandingBasicAndDiluted	18502000	usd
CY2023	rex	Income Loss Per Share From Continuing Operations Basic And Diluted IncomeLossPerShareFromContinuingOperationsBasicAndDiluted	1.57	usd
CY2022	rex	Income Loss Per Share From Continuing Operations Basic And Diluted IncomeLossPerShareFromContinuingOperationsBasicAndDiluted	2.65	usd
CY2021	rex	Net Income Per Share Basic And Diluted NetIncomePerShareBasicAndDiluted	0.16	usd
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	453606000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	5618000	usd
CY2021	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	112000	usd
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	-19629000	usd
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2928000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	404000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	437183000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	61202000	usd
CY2022	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	304000	usd
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	-6627000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	4772000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	272000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	487562000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	37937000	usd
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	-13012000	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	3998000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2505000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	510994000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	37937000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	61202000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	5618000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	4395000	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	860000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	37937000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	56807000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	4758000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17976000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18031000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18116000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5328000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5560000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5358000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1930000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1753000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	264000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	8745000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6624000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	500000	usd
CY2023	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	6266000	usd
CY2022	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	5514000	usd
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	3508000	usd
CY2023	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	-2839000	usd
CY2022	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	-43000	usd
CY2021	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	-216000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	102000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-30000	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	58000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	915000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	12730000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1110000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-659000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6108000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6744000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6519000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4799000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2307000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	452000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-199000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3243000	usd
CY2023	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-3715000	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	1103000	usd
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	276000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1478000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	16005000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-2618000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2752000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	475000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-3523000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	54795000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	98427000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	11409000	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-6716000	usd
CY2021	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-2786000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	54795000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	91711000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8623000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15578000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5126000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10412000	usd
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	399350000	usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	88949000	usd
CY2021	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	96233000	usd
CY2023	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	216735000	usd
CY2022	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	99309000	usd
CY2021	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	86328000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	5000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	60000	usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	58000	usd
CY2023	us-gaap	Payments For Deposits PaymentsForDeposits	319000	usd
CY2021	us-gaap	Payments For Deposits PaymentsForDeposits	532000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-198507000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5294000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20791000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	13012000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6627000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	19629000	usd
CY2023	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-3997000	usd
CY2022	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-4772000	usd
CY2021	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-2928000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-17009000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-11399000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-22557000	usd
CY2022	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	304000	usd
CY2021	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	112000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17009000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11095000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-22445000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-160721000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	85910000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-34613000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	232068000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	146158000	usd
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	180771000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	71347000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	232068000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	146158000	usd
CY2023	rex	Non Cash Financing Activities Equity Awards Issued NonCashFinancingActivitiesEquityAwardsIssued	1539000	usd
CY2022	rex	Non Cash Financing Activities Equity Awards Issued NonCashFinancingActivitiesEquityAwardsIssued	100000	usd
CY2021	rex	Non Cash Financing Activities Equity Awards Issued NonCashFinancingActivitiesEquityAwardsIssued	241000	usd
CY2023	rex	Non Cash Financing Activities Equity Awards Accrued NonCashFinancingActivitiesEquityAwardsAccrued	965000	usd
CY2022	rex	Non Cash Financing Activities Equity Awards Accrued NonCashFinancingActivitiesEquityAwardsAccrued	1580000	usd
CY2021	rex	Non Cash Financing Activities Equity Awards Accrued NonCashFinancingActivitiesEquityAwardsAccrued	99000	usd
CY2023	rex	Non Cash Investing Activities Accrued Capital Expenditures NonCashInvestingActivitiesAccruedCapitalExpenditures	425000	usd
CY2022	rex	Non Cash Investing Activities Accrued Capital Expenditures NonCashInvestingActivitiesAccruedCapitalExpenditures	78000	usd
CY2021	rex	Non Cash Investing Activities Accrued Capital Expenditures NonCashInvestingActivitiesAccruedCapitalExpenditures	390000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	9321000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4103000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1863000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69612000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	229846000	usd
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	144501000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1735000	usd
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	2222000	usd
CY2021Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1657000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	71347000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	232068000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	146158000	usd
CY2023	rex	Number Of Operating Entities NumberOfOperatingEntities	3	pure
CY2023	us-gaap	Fiscal Period FiscalPeriod	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-align: justify"><b><i>Fiscal Year – </i></b>All references in these consolidated financial statements to a particular fiscal year are to the Company’s fiscal year ended January 31. The Company refers to its fiscal year by reference to the year immediately preceding the January 31 fiscal year end date. For example, “fiscal year 2022” means the period February 1, 2022 to January 31, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-align: justify"><b> </b></p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-align: justify"><b><i>Use of Estimates – </i></b>The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-align: justify"> </p>
CY2023	us-gaap	Property Plant And Equipment Depreciation Methods PropertyPlantAndEquipmentDepreciationMethods	Depreciation is computed using the straight-line method
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-align: justify"><b><i>Concentrations of Risk </i></b><i>–</i>The Company maintains cash and cash equivalents in accounts with financial institutions which exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company does not believe there is significant credit risk related to its cash and cash equivalents.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-align: justify">The Company sells its products to a limited number of larger commercial buyers, which may increase the chance of loss due to non-performance by a counterparty. Eight (fiscal year 2022), nine (fiscal year 2021), and seven (fiscal year 2020) customers accounted for approximately 90%, 85%, and 89% of the</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-align: justify">Company’s net sales and revenue during fiscal years 2022, 2021, and 2020, respectively. At January 31, 2023 and 2022, four and five customers represented approximately 81% and 82%, respectively, of the Company’s accounts receivable balance. The Company has not experienced any significant losses in such accounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-align: justify"> </p>
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	700000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	500000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	12695000	usd
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	13158000	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	10194000	usd
CY2022Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	5473000	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	25855000	usd
CY2022Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	23594000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	48744000	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	42225000	usd
CY2023Q1	us-gaap	Land And Land Improvements LandAndLandImprovements	30194000	usd
CY2022Q1	us-gaap	Land And Land Improvements LandAndLandImprovements	27329000	usd
CY2023Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	23707000	usd
CY2022Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	23617000	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	299665000	usd
CY2022Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	296243000	usd
CY2023Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	10255000	usd
CY2022Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	1515000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	363821000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	348704000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	228324000	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	211150000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	135497000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	137554000	usd
CY2023	us-gaap	Depreciation Depreciation	18000000	usd
CY2022	us-gaap	Depreciation Depreciation	18000000	usd
CY2021	us-gaap	Depreciation Depreciation	18100000	usd
CY2023	rex	Outbound Freight Charges OutboundFreightCharges	6901000	usd
CY2022	rex	Outbound Freight Charges OutboundFreightCharges	7321000	usd
CY2021	rex	Outbound Freight Charges OutboundFreightCharges	3482000	usd
CY2023Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1650000	shares
CY2023	us-gaap	Interest And Fee Income Other Loans InterestAndFeeIncomeOtherLoans	7800000	usd
CY2022Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1347000	usd
CY2023	us-gaap	Revenues Revenues	855000000	usd
CY2022	us-gaap	Revenues Revenues	774802000	usd
CY2021	us-gaap	Revenues Revenues	372664000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	33045000	usd
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	30566000	usd
CY2023Q1	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.103	pure
CY2022Q1	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.103	pure
CY2023Q1	us-gaap	Commodity Contract Asset Current CommodityContractAssetCurrent	80000	usd
CY2023Q1	rex	Investment In Cooperative Fair Value Disclosure InvestmentInCooperativeFairValueDisclosure	354000	usd
CY2023Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	539000	usd
CY2023Q1	rex	Forward Purchase Contracts Liability ForwardPurchaseContractsLiability	355000	usd
CY2023Q1	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	-422000	usd
CY2022Q1	rex	Forward Purchase Contracts Asset ForwardPurchaseContractsAsset	993000	usd
CY2022Q1	us-gaap	Commodity Contract Asset Current CommodityContractAssetCurrent	933000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	21964000	usd
CY2022Q1	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	24914000	usd
CY2023Q1	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	1215000	usd
CY2022Q1	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	939000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	23179000	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	25853000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4428000	usd
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5407000	usd
CY2023Q1	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	4116000	usd
CY2022Q1	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	4297000	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1311000	usd
CY2022Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	593000	usd
CY2023Q1	rex	Commodity Futures CommodityFutures	67000	usd
CY2022Q1	rex	Commodity Futures CommodityFutures	933000	usd
CY2023Q1	rex	Forward Purchase Contracts ForwardPurchaseContracts	355000	usd
CY2023Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	1850000	usd
CY2022Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	1857000	usd
CY2023Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	2049000	usd
CY2022Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	95000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1152000	usd
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	435000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15328000	usd
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	13617000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	7360000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	6346000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	399000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	1907000	usd
CY2023	us-gaap	Lease Cost LeaseCost	7759000	usd
CY2022	us-gaap	Lease Cost LeaseCost	8253000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M12D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0551	pure
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0485	pure
CY2022	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	2	pure
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	472000	shares
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	252000	shares
CY2021	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	949000	shares
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	13000000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	6600000	usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	19600000	usd
CY2022Q1	rex	Stock Repurchase Program Number Of Additional Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased	877000	shares
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29853000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29853000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17390000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17761000	shares
CY2023Q1	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	1735000	usd
CY2022Q1	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	2222000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	450000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	97000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	30167	shares
CY2022Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValue	773000	usd
CY2022Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms In Years ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsInYears	1	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	70689	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2032000
CY2023	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	450000	shares
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	13000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	19142	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	472000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	81264	shares
CY2023Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValue	2320000	usd
CY2023Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms In Years ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsInYears	2	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	59102	shares
CY2021Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValue	1398000	usd
CY2021Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms In Years ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsInYears	1	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	8409	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	275000
CY2021	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	37344	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	900000
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	30167	shares
CY2022Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValue	773000	usd
CY2022Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms In Years ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsInYears	1	pure
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	85970	shares
CY2020Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValue	2193000	usd
CY2020Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms In Years ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsInYears	2	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	18474	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	416000
CY2020	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	0	shares
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	45342	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	1211000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	59102	shares
CY2021Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValue	1398000	usd
CY2021Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms In Years ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsInYears	1	pure
CY2023	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	67500	shares
CY2023Q1	us-gaap	Restricted Investments At Fair Value RestrictedInvestmentsAtFairValue	2700000	usd
CY2023Q1	rex	Forward Purchase Contracts Quantity ForwardPurchaseContractsQuantity	18000000	bu
CY2023Q1	rex	Quantity Of Natural Gas Under Sales Commitmen QuantityOfNaturalGasUnderSalesCommitmen	2.7	mmbtu
CY2023	us-gaap	Payments To Acquire Projects PaymentsToAcquireProjects	29300000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4485000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4450000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1323000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2925000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	12064000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1850000	usd
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	7410000	usd
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	16514000	usd
CY2021	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-527000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	4167000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3098000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	602000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2035000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-581000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-621000	usd
CY2023	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	2132000	usd
CY2022	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	2517000	usd
CY2021	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-19000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9542000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19031000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-546000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	26061000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	39199000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	627000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	582000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	244000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	269000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	240000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	280000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	192000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	213000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	26980000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	40117000	usd
CY2023Q1	rex	Deferred Tax Liabilities Basis In Pass Through Entities Including Depreciation DeferredTaxLiabilitiesBasisInPassThroughEntitiesIncludingDepreciation	5821000	usd
CY2022Q1	rex	Deferred Tax Liabilities Basis In Pass Through Entities Including Depreciation DeferredTaxLiabilitiesBasisInPassThroughEntitiesIncludingDepreciation	17995000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	292000	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	340000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6113000	usd
CY2022Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	18335000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	20867000	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	21782000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	26100000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	39200000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	192000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	213000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	21000	usd
CY2022Q1	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	11300000	usd
CY2021Q1	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	5200000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	400000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	-3000000	usd
CY2021Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	900000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	2795000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	7239000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	1274000	usd
CY2021	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	655000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	9971000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	15926000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	885000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1725000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2396000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	150000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	2542000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	5184000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	2008000	usd
CY2023	rex	Effective Income Tax Reconciliation Uncertain Tax Position EffectiveIncomeTaxReconciliationUncertainTaxPosition	2281000	usd
CY2022	rex	Effective Income Tax Reconciliation Uncertain Tax Position EffectiveIncomeTaxReconciliationUncertainTaxPosition	8340000	usd
CY2021	rex	Effective Income Tax Reconciliation Uncertain Tax Position EffectiveIncomeTaxReconciliationUncertainTaxPosition	1046000	usd
CY2023	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	2523000	usd
CY2022	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	2231000	usd
CY2021	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	707000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	630000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-216000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	88000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	9542000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	19031000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-546000	usd
CY2023Q1	rex	Unrecognized Tax Benefits Without Accrued Penalties And Interest UnrecognizedTaxBenefitsWithoutAccruedPenaltiesAndInterest	19033000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	55000	usd
CY2023	rex	Increase Decrease In Provision For Income Taxes IncreaseDecreaseInProvisionForIncomeTaxes	-18925000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	16781000	usd
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8400000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	165000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	3827000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2142000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	4554000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	19088000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	16781000	usd
CY2023	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif"> <td style="width: 24pt; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0pt">13.</td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-indent: 0pt">CONTINGENCIES</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">The Company is involved in various legal actions arising in the normal course of business. After taking into consideration legal counsels’ evaluation of such actions, management is of the opinion that their outcome will not have a material effect on the Company’s consolidated financial statements. The Company recorded a liability of $250,000 at January 31, 2023 as a probable and reasonably estimable loss associated with a legal contingency for a patent infringement case involving our refined coal facility which is no longer in operation. There were no liabilities recorded at January 31, 2022 as the Company did not believe that there was a probable and reasonably estimable loss associated with any legal contingencies.</p>
CY2023	us-gaap	Legal Fees LegalFees	250000	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	182000	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	8602000	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	5854000	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	-8202000	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	-5672000	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	698000	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	22000	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Other Income DisposalGroupIncludingDiscontinuedOperationOtherIncome	-8900000	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation Other Income DisposalGroupIncludingDiscontinuedOperationOtherIncome	-5694000	usd
CY2022	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-13295000	usd
CY2021	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-6554000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	4395000	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	860000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-397000	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-261000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	4792000	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	1121000	usd
CY2022Q2	us-gaap	Revenues Revenues	194228000	usd
CY2022Q3	us-gaap	Revenues Revenues	240328000	usd
CY2022Q4	us-gaap	Revenues Revenues	220277000	usd
CY2023Q1	us-gaap	Revenues Revenues	200167000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	11912000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	16584000	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	11336000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	14899000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	6986000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	14885000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	4898000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	11168000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5182000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11170000	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3184000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8161000	usd
CY2022Q2	rex	Basic And Diluted Netloss Income Per Share Attributable To Rex Common Shareholdersin BasicAndDilutedNetlossIncomePerShareAttributableToREXCommonShareholdersin	0.29
CY2022Q3	rex	Basic And Diluted Netloss Income Per Share Attributable To Rex Common Shareholdersin BasicAndDilutedNetlossIncomePerShareAttributableToREXCommonShareholdersin	0.63
CY2022Q4	rex	Basic And Diluted Netloss Income Per Share Attributable To Rex Common Shareholdersin BasicAndDilutedNetlossIncomePerShareAttributableToREXCommonShareholdersin	0.18
CY2023Q1	rex	Basic And Diluted Netloss Income Per Share Attributable To Rex Common Shareholdersin BasicAndDilutedNetlossIncomePerShareAttributableToREXCommonShareholdersin	0.47
CY2021Q2	us-gaap	Revenues Revenues	164042000	usd
CY2021Q3	us-gaap	Revenues Revenues	195678000	usd
CY2021Q4	us-gaap	Revenues Revenues	203066000	usd
CY2022Q1	us-gaap	Revenues Revenues	212016000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	19477000	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	14154000	usd
CY2021Q4	us-gaap	Gross Profit GrossProfit	25152000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	38777000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	7963000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	8039000	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	14888000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	25917000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	7269000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	5710000	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	13326000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	21267000	usd
CY2021Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	515000	usd
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	2166000	usd
CY2021Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	1952000	usd
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	159000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7784000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7876000	usd
CY2021Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	15278000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	21426000	usd
CY2021Q2	rex	Basic And Diluted Netloss Income Per Share Attributable To Rex Common Shareholdersd BasicAndDilutedNetlossIncomePerShareAttributableToREXCommonShareholdersd	0.4
CY2021Q3	rex	Basic And Diluted Netloss Income Per Share Attributable To Rex Common Shareholdersd BasicAndDilutedNetlossIncomePerShareAttributableToREXCommonShareholdersd	0.32
CY2021Q4	rex	Basic And Diluted Netloss Income Per Share Attributable To Rex Common Shareholdersd BasicAndDilutedNetlossIncomePerShareAttributableToREXCommonShareholdersd	0.74
CY2022Q1	rex	Basic And Diluted Netloss Income Per Share Attributable To Rex Common Shareholdersd BasicAndDilutedNetlossIncomePerShareAttributableToREXCommonShareholdersd	1.19
CY2021Q2	rex	Basic And Diluted Netloss Income Per Share Attributable To Rex Common Shareholdersc BasicAndDilutedNetlossIncomePerShareAttributableToREXCommonShareholdersc	0.03
CY2021Q3	rex	Basic And Diluted Netloss Income Per Share Attributable To Rex Common Shareholdersc BasicAndDilutedNetlossIncomePerShareAttributableToREXCommonShareholdersc	0.12
CY2021Q4	rex	Basic And Diluted Netloss Income Per Share Attributable To Rex Common Shareholdersc BasicAndDilutedNetlossIncomePerShareAttributableToREXCommonShareholdersc	0.11
CY2022Q1	rex	Basic And Diluted Netloss Income Per Share Attributable To Rex Common Shareholdersc BasicAndDilutedNetlossIncomePerShareAttributableToREXCommonShareholdersc	0.01
CY2021Q2	rex	Basic And Diluted Netloss Income Per Share Attributable To Rex Common Shareholdersin BasicAndDilutedNetlossIncomePerShareAttributableToREXCommonShareholdersin	0.43
CY2021Q3	rex	Basic And Diluted Netloss Income Per Share Attributable To Rex Common Shareholdersin BasicAndDilutedNetlossIncomePerShareAttributableToREXCommonShareholdersin	0.44
CY2021Q4	rex	Basic And Diluted Netloss Income Per Share Attributable To Rex Common Shareholdersin BasicAndDilutedNetlossIncomePerShareAttributableToREXCommonShareholdersin	0.85
CY2022Q1	rex	Basic And Diluted Netloss Income Per Share Attributable To Rex Common Shareholdersin BasicAndDilutedNetlossIncomePerShareAttributableToREXCommonShareholdersin	1.2
CY2023	dei	Auditor Name AuditorName	Deloitte and Touche LLP
CY2023	dei	Auditor Location AuditorLocation	Dayton, Ohio
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000744187

Files In Submission

Name	View Source	Status
0000930413-23-001143-index-headers.html	Edgar Link	pending
0000930413-23-001143-index.html	Edgar Link	pending
0000930413-23-001143.txt	Edgar Link	pending
0000930413-23-001143-xbrl.zip	Edgar Link	pending
c106065_10k-ixbrl.htm	Edgar Link	pending
c106065_ex21.htm	Edgar Link	pending
c106065_ex23.htm	Edgar Link	pending
c106065_ex31.htm	Edgar Link	pending
c106065_ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rex-20230131.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
x1_c106065x22x1.jpg	Edgar Link	pending
rex-20230131_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
rex-20230131_def.xml	Edgar Link	unprocessable
rex-20230131_pre.xml	Edgar Link	unprocessable
rex-20230131_lab.xml	Edgar Link	unprocessable
c106065_10k-ixbrl_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$REX
REX American Resources Corp Stock $rex

2023 Q1 Form 10-K Financial Statement

#000093041323001143 Filed on March 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REX REX American Resources Corp Stock $rex

2023 Q1 Form 10-K Financial Statement

#000093041323001143 Filed on March 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REX
REX American Resources Corp Stock $rex